Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Rodriguez 2025 (EHR, n=125,474): 1-year discontinuation 64.8% in non-diabetics vs 46.5% in type 2 diabetes
The initial findings were so impressive that some researchers suggested BPC-157 could be the prototype of a new class of organoprotective agents. There were still many unanswered questions, though: Would other studies replicate these findings
Phase 2 trial data (Jastreboff et al., NEJM 2023) demonstrated average weight reductions of approximately 1724% over 48 weeks notably higher than currently approved GLP-1 receptor agonists such as semaglutide, though direct comparisons are limited by differences in trial populations and designs
Dec 14, 2025 BPC-157 is one of the most talked-about peptides in the biohacking world
Reconstitution AOD 9604 typically comes as lyophilized powder requiring reconstitution with bacteriostatic water
Health history, medications, pregnancy status, breastfeeding, and treatment goals all matter
US$ 25.95
US$ 20.01
US$ 22.67